Intervention Protocol

You have free access to this content

Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplasty

  1. Mohsen Sadeghi-Naini1,*,
  2. Toby O Smith2,
  3. Jaleh Gholami3,
  4. Saharnaz Nedjat4,
  5. Caroline B Hing5,
  6. Mansour Abolghasemian6

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 2 NOV 2013

DOI: 10.1002/14651858.CD010812


How to Cite

Sadeghi-Naini M, Smith TO, Gholami J, Nedjat S, Hing CB, Abolghasemian M. Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplasty (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010812. DOI: 10.1002/14651858.CD010812.

Author Information

  1. 1

    Tehran University of Medical Sciences, Multidisciplinary Orthopedic and Rheumatologic research association (MORRA), Tehran, Iran

  2. 2

    University of East Anglia, Faculty of Medicine and Health Sciences, Norwich, Norfolk, UK

  3. 3

    Tehran University of Medical Sciences, Faculty of Public Health, Tehran, Iran

  4. 4

    Tehran University of Medical Sciences (TUMS), School of Public Health, Tehran, Iran

  5. 5

    St George's Hospital, Department of Trauma and Orthopaedic Surgery, London, UK

  6. 6

    Shafa Hospital, Tehran University of Medical Sciences, Department of Orthopaedics, Tehran, Iran

*Mohsen Sadeghi-Naini, Multidisciplinary Orthopedic and Rheumatologic research association (MORRA), Tehran University of Medical Sciences, Num 56 - Vesal street, Enghelab Avenue, Tehran, 1417755331, Iran. dr.msadeghi313@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 2 NOV 2013

SEARCH

References

Additional references

Adler 2011
Atkins 2004
  • Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al. GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 2004;4(1):38. [PUBMED: 15615589]
Avenell 2009
Bobyn 1992
  • Bobyn JD, Mortimer ES, Glassman AH, Engh CA, Miller JE, Brooks CE. Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clinical Orthopaedics and Related Research 1992;274:79-96. [PUBMED: 1729025]
Brodner 2004
  • Brodner W, Bitzan P, Lomoschitz F, Krepler P, Jankovsky R, Lehr S, et al. Changes in bone mineral density in the proximal femur after cementless total hip arthroplasty. A five-year longitudinal study. The Journal of Bone and Joint Surgery [British volume] 2004;86(1):20-6. [PUBMED: 14765859]
Conwell 2012
Cosman 2005
  • Cosman F. The prevention and treatment of osteoporosis: a review. Medscape General Medicine 2005;7(2):73. [PUBMED: 16369451]
Cranney 2000
  • Cranney A, Welch V, Adachi J, Homik J, Shea B, Suarez-Almazor ME, et al. Calcitonin for preventing and treating corticosteroid-induced osteoporosis. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001983]
Deeks 2011
  • Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Fatima 2011
  • Fatima de Pina M, Ribeiro A, Santos C. Epidemiology and variability of orthopaedic procedures worldwide. In: Bentley George editor(s). European Instructional Lectures. 11. Berlin Heidelberg: Springer, 2011:9-19.
Furnes 2001
  • Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI. Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99. The Journal of Bone and Joint Surgery [British volume] 2001;83(4):579-86. [PUBMED: 11380136]
Gennari 2012
  • Gennari L, Merlotti D, Stolakis K, Nuti R. Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis. Expert Opinion on Drug Metabolism & Toxicology 2012;8(4):505-13. [PUBMED: 22356442]
Gruen 1979
  • Gruen TA, McNeice GM, Amstutz HC. "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clinical Orthopaedics and Related Research 1979;141:17-27. [PUBMED: 477100]
Higgins 2011a
  • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
  • Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, et al. Chapter 15: Selecting studies and including data. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org 2011.
Higgins 2011c
  • Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Holt 2007
  • Holt G, Murnaghan C, Reilly J, Meek RM. The biology of aseptic osteolysis. Clinical Orthopaedics and Related Research 2007;460:240-52. [PUBMED: 17620815]
Homik 1998
  • Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells GA, Tugwell P. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD000952]
Homik 1999
  • Homik J, Cranney A, Shea B, Tugwell P, Wells GA, Adachi J, et al. Bisphosphonates for steroid induced osteoporosis. Cochrane Database of Systematic Reviews 1999, Issue 1. [DOI: 10.1002/14651858.CD001347]
Karsdal 2008
  • Karsdal MA, Byrjalsen I, Riis BJ, Christiansen C. Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin. BMC Clinical Pharmacology 2008;8:12. [PUBMED: 19055791]
Kiratli 1996
  • Kiratli BJ, Checovich MM, McBeath AA, Wilson MA, Heiner JP. Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem. The Journal of Arthroplasty 1996;11(2):184-93. [PUBMED: 8648314]
Kress 2012
  • Kress AM, Schmidt R, Nowak TE, Nowak M, Haeberle L, Forst R, et al. Stress-related femoral cortical and cancellous bone density loss after collum femoris preserving uncemented total hip arthroplasty: a prospective 7-year follow-up with quantitative computed tomography. Archives of Orthopaedic and Trauma Surgery 2012;132(8):1111-9. [PUBMED: 22622793]
Kroger 1998
  • Kroger H, Venesmaa P, Jurvelin J, Miettinen H, Suomalainen O, Alhava E. Bone density at the proximal femur after total hip arthroplasty. Clinical Orthopaedics and Related Research 1998;352:66-74. [PUBMED: 9678034]
Lingard 2010
  • Lingard EA, Mitchell SY, Francis RM, Rawlings D, Peaston R, Birrell FN, et al. The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty. Age and Ageing 2010;39(2):234-9. [PUBMED: 20032523]
Meek 2011
  • Meek RM, Norwood T, Smith R, Brenkel IJ, Howie CR. The risk of peri-prosthetic fracture after primary and revision total hip and knee replacement. The Journal of Bone and Joint Surgery [British volume] 2011;93(1):96-101. [PUBMED: 21196551]
Mirsky 1998
  • Mirsky EC, Einhorn TA. Bone densitometry in orthopaedic practice. The Journal of Bone and Joint Surgery [American volume] 1998;80(11):1687-98. [PUBMED: 9840640]
Mitchell 1999
  • Mitchell DY, Heise MA, Pallone KA, Clay ME, Nesbitt JD, Russell DA, et al. The effect of dosing regimen on the pharmacokinetics of risedronate. British Journal of Clinical Pharmacology 1999;48(4):536-42. [PUBMED: 10583024]
Mueller 2010
  • Mueller LA, Nowak TE, Haeberle L, Mueller LP, Kress A, Voelk M, et al. Progressive femoral cortical and cancellous bone density loss after uncemented tapered-design stem fixation. Acta Orthopaedica 2010;81(2):171-7. [PUBMED: 20180716]
O'Donnell 2006
Peichl 2005
  • Peichl P, Marteau R, Griesmacher A, Kumpan W, Schedl R, Prosquil E, et al. Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty. Journal of Bone and Mineral Metabolism 2005;23(3):243-52. [PUBMED: 15838628]
Rodriguez 2012
  • Rodriguez J, Escudero ND, Mandalunis PM. Effect of strontium ranelate on bone remodeling. Acta Odontologica Latinoamericana : AOL 2012;25(2):208-13. [PUBMED: 23230643]
Sabo 1998
  • Sabo D, Reiter A, Simank HG, Thomsen M, Lukoschek M, Ewerbeck V. Periprosthetic mineralization around cementless total hip endoprosthesis: longitudinal study and cross-sectional study on titanium threaded acetabular cup and cementless Spotorno stem with DEXA. Calcified Tissue International 1998;62(2):177-82. [PUBMED: 9437053]
Satterwhite 2010
  • Satterwhite J, Heathman M, Miller PD, Marin F, Glass EV, Dobnig H. Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis. Calcified Tissue International 2010;87(6):485-92. [PUBMED: 20953593]
Schunemann 2011
  • Schunemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH (editors). Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Shanbhag 2006
  • Shanbhag AS. Use of bisphosphonates to improve the durability of total joint replacements. The Journal of the American Academy of Orthopaedic Surgeons 2006;14(4):215-25. [PUBMED: 16585363]
Wells 2008a
  • Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Welch V, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD001155.pub2]
Wells 2008b
  • Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Welch V, et al. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003376.pub3]
Wells 2008c
  • Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Welch V, et al. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD004523.pub3]
Wilkinson 2001a
Wilkinson 2001b
  • Wilkinson JM, Peel NF, Elson RA, Stockley I, Eastell R. Measuring bone mineral density of the pelvis and proximal femur after total hip arthroplasty. The Journal of Bone and Joint Surgery [British volume] 2001;83(2):283-8. [PUBMED: 11284582]
Yoshida 2012
Zhu 2012